Autoimmune Disease Diagnostics: Global Markets
Report Scope:
This report aims to study the autoimmune disease diagnostics global market size comprehensively. Current and historical market revenues can be estimated based on the technology, by indication, gender and region.
Report Includes:
This report aims to study the autoimmune disease diagnostics global market size comprehensively. Current and historical market revenues can be estimated based on the technology, by indication, gender and region.
Report Includes:
- 41 data tables and 30 additional tables
- An overview of the global market landscape related to the autoimmune disease diagnostics
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to autoimmune disease diagnostics, accompanied by a comprehensive market share analysis categorized by technology, indication, gender, and geographical region
- Detailed description of autoimmune disorder & therapies, and causes such as intrinsic factors, environmental factors, and lifestyle factors, and insights into new diagnostic pathway for autoimmune and inflammatory disorders
- Discussion on role of bioinformatics and biomarkers on autoimmune disorder therapies and information on standardization of test results
- Coverage of new product launches in the therapeutics for autoimmune diseases and performance methods in the detection of autoimmune antibodies
- Coverage of emerging technologies in autoimmune disease diagnostics, recent developments, future opportunities, patent review, and ESG trends
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Detailed profiles of leading market participants, including Abbott, Beckman Coulter Inc., BioMйrieux, Siemens Healthcare, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
What’s New in This Update?
Scope of Report
Methodology
Information Sources
Secondary Research
Geographic Breakdown
Segmentation Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Outlook
Market Summary
CHAPTER 3 MARKET OVERVIEW AND DEFINITIONS
Overview: Autoimmune Disease Diagnostics
Enzyme-|Linked Immunosorbent Assay (ELISA)
Indirect Immunofluorescence (IIF)
Multiplex Immunoassays
Western Blot (Immunoblot)
Other Technologies
Indications
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Psoriatic Arthritis
Multiple Sclerosis
Inflammatory Bowel Disease
The Global Regulatory Structure for Autoimmune Disease Diagnostics
Test Validation
FDA Clearance or Approval
Good Manufacturing Practices (GMP)
Labeling and Instructions
Post-Market Surveillance
Quality Control and Quality Assurance
Clinical Utility and Medical Guidelines
Privacy and Data Security
Regulatory Scenario
North American Regulations
Latin American Regulations
Asia-Pacific Regulations
CHAPTER 4 MARKET DYNAMICS
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
CHAPTER 5 MARKET BREAKDOWN BY REGION
Market Overview and Discussion
North America
Mexico
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia and New Zealand
Rest of Asia-Pacific
Rest of the World
CHAPTER 6 MARKET BREAKDOWN BY GENDER
Market Overview and Discussion
Male
Female
North American Market by Gender
European Market by Gender
Asia-Pacific Market by Gender
Rest of the World Market by Gender
CHAPTER 7 MARKET BREAKDOWN BY INDICATION
Market Overview and Discussion
Type 1 Diabetes
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Psoriasis/Psoriatic Arthritis
Multiple Sclerosis
Inflammatory Bowel Disease
Other Indications
CHAPTER 8 MARKET BREAKDOWN BY TECHNOLOGY
Enzyme-Linked Immunosorbent Assay (ELISA)
Regional Markets
Indirect Immunofluorescence (IIF)
Regional Markets
Immunoblot
Regional Markets
Multiplex Immunoassays
Regional Markets
Others
Regional Markets
CHAPTER 9 ESG DEVELOPMENT
Introduction
Environment
Research Practices
Supply Chain Sustainability
Waste Management
Energy Efficiency
Social
Access to Healthcare
Patient Well-Being
Community Engagement
Governance
Ethical Business Practices
Compliance with Regulations
Board Diversity
Transparency and Accountability
Case Study
Roche
Sustainability at Roche
Concluding Remarks from BCC Research
CHAPTER 10 EMERGING TRENDS AND TECHNOLOGIES
Introduction
CHAPTER 11 COMPETITIVE LANDSCAPE
Overview
Industry Scenario
Company Shares
CHAPTER 12 PATENT ANALYSIS
Patent Analysis by Manufacturer
CHAPTER 13 PIPELINE ANALYSIS
Clinical Trials
CHAPTER 14 M&A AND VENTURE FUNDING OUTLOOK
Introduction
CHAPTER 15 COMPANY PROFILES
ABBOTT
BD BIOSCIENCES
BECKMAN COULTER INC.
BIOMERIEUX
BIO-RAD (ABD SEROTEC)
F. HOFFMANN-LA ROCHE AG
QUEST DIAGNOSTICS INC.
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.
CHAPTER 16 APPENDIX: ACRONYMS
Study Goals and Objectives
Reasons for Doing This Study
What’s New in This Update?
Scope of Report
Methodology
Information Sources
Secondary Research
Geographic Breakdown
Segmentation Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Outlook
Market Summary
CHAPTER 3 MARKET OVERVIEW AND DEFINITIONS
Overview: Autoimmune Disease Diagnostics
Enzyme-|Linked Immunosorbent Assay (ELISA)
Indirect Immunofluorescence (IIF)
Multiplex Immunoassays
Western Blot (Immunoblot)
Other Technologies
Indications
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Psoriatic Arthritis
Multiple Sclerosis
Inflammatory Bowel Disease
The Global Regulatory Structure for Autoimmune Disease Diagnostics
Test Validation
FDA Clearance or Approval
Good Manufacturing Practices (GMP)
Labeling and Instructions
Post-Market Surveillance
Quality Control and Quality Assurance
Clinical Utility and Medical Guidelines
Privacy and Data Security
Regulatory Scenario
North American Regulations
Latin American Regulations
Asia-Pacific Regulations
CHAPTER 4 MARKET DYNAMICS
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
CHAPTER 5 MARKET BREAKDOWN BY REGION
Market Overview and Discussion
North America
Mexico
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia and New Zealand
Rest of Asia-Pacific
Rest of the World
CHAPTER 6 MARKET BREAKDOWN BY GENDER
Market Overview and Discussion
Male
Female
North American Market by Gender
European Market by Gender
Asia-Pacific Market by Gender
Rest of the World Market by Gender
CHAPTER 7 MARKET BREAKDOWN BY INDICATION
Market Overview and Discussion
Type 1 Diabetes
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Psoriasis/Psoriatic Arthritis
Multiple Sclerosis
Inflammatory Bowel Disease
Other Indications
CHAPTER 8 MARKET BREAKDOWN BY TECHNOLOGY
Enzyme-Linked Immunosorbent Assay (ELISA)
Regional Markets
Indirect Immunofluorescence (IIF)
Regional Markets
Immunoblot
Regional Markets
Multiplex Immunoassays
Regional Markets
Others
Regional Markets
CHAPTER 9 ESG DEVELOPMENT
Introduction
Environment
Research Practices
Supply Chain Sustainability
Waste Management
Energy Efficiency
Social
Access to Healthcare
Patient Well-Being
Community Engagement
Governance
Ethical Business Practices
Compliance with Regulations
Board Diversity
Transparency and Accountability
Case Study
Roche
Sustainability at Roche
Concluding Remarks from BCC Research
CHAPTER 10 EMERGING TRENDS AND TECHNOLOGIES
Introduction
CHAPTER 11 COMPETITIVE LANDSCAPE
Overview
Industry Scenario
Company Shares
CHAPTER 12 PATENT ANALYSIS
Patent Analysis by Manufacturer
CHAPTER 13 PIPELINE ANALYSIS
Clinical Trials
CHAPTER 14 M&A AND VENTURE FUNDING OUTLOOK
Introduction
CHAPTER 15 COMPANY PROFILES
ABBOTT
BD BIOSCIENCES
BECKMAN COULTER INC.
BIOMERIEUX
BIO-RAD (ABD SEROTEC)
F. HOFFMANN-LA ROCHE AG
QUEST DIAGNOSTICS INC.
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.
CHAPTER 16 APPENDIX: ACRONYMS
LIST OF TABLES
Summary Table : Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2028
Table 1 : Components of ELISA
Table 2 : Process of ELISA
Table 3 : Components of Immunofluorescence (IIF)
Table 4 : Process of Immunofluorescence (IIF)
Table 5 : Types of Agglutination Test
Table 6 : Global Market for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 7 : North American Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 8 : European Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 9 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 10 : Rest of the World Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 11 : Global Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 12 : North American Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 13 : European Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 14 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 15 : Rest of the World Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 16 : Global Market for Autoimmune Disease Diagnostics, by Indication, Through 2028
Table 17 : Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, Through 2028
Table 18 : Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, Through 2028
Table 19 : Global Market for Autoimmune Disease Diagnostics for SLE, by Region, Through 2028
Table 20 : Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, Through 2028
Table 21 : Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, Through 2028
Table 22 : Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, Through 2028
Table 23 : Global Market for Autoimmune Disease Diagnostics for Other Disease Indications, by Region, Through 2028
Table 24 : Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2028
Table 25 : Global Market for ELISA for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 26 : Global Market for Indirect Immunofluorescence (IIF) for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 27 : Global Market for Immunoblot for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 28 : Global Market for Multiplex Immunoassays for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 29 : Global Market for Other Technologies for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 30 : ESG Frameworks for the Global Autoimmune Disease Diagnostics Market
Table 31 : Environmental (E) Factors in Autoimmune Disease Diagnostics
Table 32 : Social Framework, Global Autoimmune Disease Diagnostics
Table 33 : Social (S) Factors in Autoimmune Disease Diagnostics
Table 34 : Governance (G) Factors in Autoimmune Disease Diagnostics
Table 35 : Top Pharma Companies, ESG Ratings, 2022
Table 36 : Sustainability at Roche, 2022
Table 37 : Roche's Ten-Year Ambitions
Table 38 : Global Autoimmune Disease Diagnostics Emerging Trends and Technologies
Table 39 : Global Company Market Shares of Autoimmune Disease Diagnostics, 2022
Table 40 : Patents on ELISA, 2018–Present
Table 41 : Selected Manufacturer Patents on ELISA, 2018–Present
Table 42 : Patents on Indirect Immunofluorescence, 2018–Present
Table 43 : Selected Manufacturer Patents on Indirect Immunofluorescence, 2018–Present
Table 44 : Patents on Western Blot, 2018–Present
Table 45 : Selected Manufacturer Patents on Western Blot, 2018–Present
Table 46 : Clinical Trials on Type 1 Diabetes Diagnostics, as of 2023
Table 47 : Clinical Trials on Rheumatoid Arthritis Diagnostics, as of 2023
Table 48 : Clinical Trials on Systemic Lupus Erythematosus Diagnostics, as of 2023
Table 49 : Clinical Trials on Psoriasis Diagnostics, as of 2023
Table 50 : Clinical Trials on Multiple Sclerosis Diagnostics, as of 2023
Table 51 : Clinical Trials on Inflammatory Bowel Disease Diagnostics, as of 2023
Table 52 : Global Autoimmune Disease Diagnostics Market: Mergers and Acquisitions, 2023
Table 53 : Abbott: Product Information
Table 54 : Abbott: Revenue, 2020-2022
Table 55 : BD Biosciences: Product Information
Table 56 : BD Biosciences: Revenue, 2020-2022
Table 57 : Beckman Coulter Inc. (Danaher): Product Portfolio
Table 58 : Danaher: Revenue, 2020-2022
Table 59 : BioMйrieux: Product Portfolio
Table 60 : BioMйrieux: Revenue, 2020-2022
Table 61 : Bio-Rad: Product Portfolio
Table 62 : Bio-Rad: Revenue, 2020-2022
Table 63 : F. Hoffmann-La Roche AG: Product Portfolio
Table 64 : F. Hoffmann-La Roche AG: Revenue, 2020-2022
Table 65 : Quest Diagnostics: Revenue, 2020-2022
Table 66 : Siemens Healthcare: Product Portfolio
Table 67 : Siemens Healthcare: Revenue, 2020-2022
Table 68 : Thermo Fisher Scientific: Product Portfolio
Table 69 : Thermo Fisher Scientific: Revenue, 2020-2022
Table 70 : Major Acronyms Used in This Report
Summary Table : Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2028
Table 1 : Components of ELISA
Table 2 : Process of ELISA
Table 3 : Components of Immunofluorescence (IIF)
Table 4 : Process of Immunofluorescence (IIF)
Table 5 : Types of Agglutination Test
Table 6 : Global Market for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 7 : North American Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 8 : European Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 9 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 10 : Rest of the World Market for Autoimmune Disease Diagnostics, by Country, Through 2028
Table 11 : Global Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 12 : North American Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 13 : European Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 14 : Asia-Pacific Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 15 : Rest of the World Market for Autoimmune Disease Diagnostics, by Gender, Through 2028
Table 16 : Global Market for Autoimmune Disease Diagnostics, by Indication, Through 2028
Table 17 : Global Market for Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, Through 2028
Table 18 : Global Market for Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, Through 2028
Table 19 : Global Market for Autoimmune Disease Diagnostics for SLE, by Region, Through 2028
Table 20 : Global Market for Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, Through 2028
Table 21 : Global Market for Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, Through 2028
Table 22 : Global Market for Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, Through 2028
Table 23 : Global Market for Autoimmune Disease Diagnostics for Other Disease Indications, by Region, Through 2028
Table 24 : Global Market for Autoimmune Disease Diagnostics, by Technology, Through 2028
Table 25 : Global Market for ELISA for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 26 : Global Market for Indirect Immunofluorescence (IIF) for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 27 : Global Market for Immunoblot for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 28 : Global Market for Multiplex Immunoassays for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 29 : Global Market for Other Technologies for Autoimmune Disease Diagnostics, by Region, Through 2028
Table 30 : ESG Frameworks for the Global Autoimmune Disease Diagnostics Market
Table 31 : Environmental (E) Factors in Autoimmune Disease Diagnostics
Table 32 : Social Framework, Global Autoimmune Disease Diagnostics
Table 33 : Social (S) Factors in Autoimmune Disease Diagnostics
Table 34 : Governance (G) Factors in Autoimmune Disease Diagnostics
Table 35 : Top Pharma Companies, ESG Ratings, 2022
Table 36 : Sustainability at Roche, 2022
Table 37 : Roche's Ten-Year Ambitions
Table 38 : Global Autoimmune Disease Diagnostics Emerging Trends and Technologies
Table 39 : Global Company Market Shares of Autoimmune Disease Diagnostics, 2022
Table 40 : Patents on ELISA, 2018–Present
Table 41 : Selected Manufacturer Patents on ELISA, 2018–Present
Table 42 : Patents on Indirect Immunofluorescence, 2018–Present
Table 43 : Selected Manufacturer Patents on Indirect Immunofluorescence, 2018–Present
Table 44 : Patents on Western Blot, 2018–Present
Table 45 : Selected Manufacturer Patents on Western Blot, 2018–Present
Table 46 : Clinical Trials on Type 1 Diabetes Diagnostics, as of 2023
Table 47 : Clinical Trials on Rheumatoid Arthritis Diagnostics, as of 2023
Table 48 : Clinical Trials on Systemic Lupus Erythematosus Diagnostics, as of 2023
Table 49 : Clinical Trials on Psoriasis Diagnostics, as of 2023
Table 50 : Clinical Trials on Multiple Sclerosis Diagnostics, as of 2023
Table 51 : Clinical Trials on Inflammatory Bowel Disease Diagnostics, as of 2023
Table 52 : Global Autoimmune Disease Diagnostics Market: Mergers and Acquisitions, 2023
Table 53 : Abbott: Product Information
Table 54 : Abbott: Revenue, 2020-2022
Table 55 : BD Biosciences: Product Information
Table 56 : BD Biosciences: Revenue, 2020-2022
Table 57 : Beckman Coulter Inc. (Danaher): Product Portfolio
Table 58 : Danaher: Revenue, 2020-2022
Table 59 : BioMйrieux: Product Portfolio
Table 60 : BioMйrieux: Revenue, 2020-2022
Table 61 : Bio-Rad: Product Portfolio
Table 62 : Bio-Rad: Revenue, 2020-2022
Table 63 : F. Hoffmann-La Roche AG: Product Portfolio
Table 64 : F. Hoffmann-La Roche AG: Revenue, 2020-2022
Table 65 : Quest Diagnostics: Revenue, 2020-2022
Table 66 : Siemens Healthcare: Product Portfolio
Table 67 : Siemens Healthcare: Revenue, 2020-2022
Table 68 : Thermo Fisher Scientific: Product Portfolio
Table 69 : Thermo Fisher Scientific: Revenue, 2020-2022
Table 70 : Major Acronyms Used in This Report
LIST OF FIGURES
Summary Figure : Global Market Shares of Autoimmune Disease Diagnostics, by Technology Type, 2022
Figure 1 : Enzyme-Linked Immunosorbent Assay (ELISA)
Figure 2 : Indirect Immunofluorescence (IIF)
Figure 3 : Western Blot (Immunoblot)
Figure 4 : Rheumatoid Arthritis
Figure 5 : SLE
Figure 6 : Global Market Shares of Autoimmune Disease Diagnostics, by Region, 2022
Figure 7 : North American Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 8 : European Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 9 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 10 : Global Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 11 : North American Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 12 : European Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 13 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 14 : Rest of the World Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 15 : Global Market Shares of Autoimmune Disease Diagnostics, by Indication, 2022
Figure 16 : Global Market Shares of Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, 2022
Figure 17 : Global Market Shares of Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, 2022
Figure 18 : Global Market Shares of Autoimmune Disease Diagnostics for SLE, by Region, 2022
Figure 19 : Global Market Shares of Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, 2022
Figure 20 : Global Market Shares of Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, 2022
Figure 21 : Global Market Shares of Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, 2022
Figure 22 : Global Market Shares of Autoimmune Disease Diagnostics for Other Disease Indications, by Region, 2022
Figure 23 : Global Market Shares of Autoimmune Disease Diagnostics, by Technology, 2022
Figure 24 : Global Electricity Produced from Renewable Sources, 2017–2021
Figure 25 : Global Recycled Waste, 2017-2021
Figure 26 : Global CO2 Emissions, 2017–2021
Figure 27 : Global Company Market Shares of Autoimmune Disease Diagnostics, 2022
Summary Figure : Global Market Shares of Autoimmune Disease Diagnostics, by Technology Type, 2022
Figure 1 : Enzyme-Linked Immunosorbent Assay (ELISA)
Figure 2 : Indirect Immunofluorescence (IIF)
Figure 3 : Western Blot (Immunoblot)
Figure 4 : Rheumatoid Arthritis
Figure 5 : SLE
Figure 6 : Global Market Shares of Autoimmune Disease Diagnostics, by Region, 2022
Figure 7 : North American Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 8 : European Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 9 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Country, 2022
Figure 10 : Global Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 11 : North American Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 12 : European Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 13 : Asia-Pacific Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 14 : Rest of the World Market Shares of Autoimmune Disease Diagnostics, by Gender, 2022
Figure 15 : Global Market Shares of Autoimmune Disease Diagnostics, by Indication, 2022
Figure 16 : Global Market Shares of Autoimmune Disease Diagnostics for Type 1 Diabetes, by Region, 2022
Figure 17 : Global Market Shares of Autoimmune Disease Diagnostics for Rheumatoid Arthritis, by Region, 2022
Figure 18 : Global Market Shares of Autoimmune Disease Diagnostics for SLE, by Region, 2022
Figure 19 : Global Market Shares of Autoimmune Disease Diagnostics for Psoriasis/Psoriatic Arthritis, by Region, 2022
Figure 20 : Global Market Shares of Autoimmune Disease Diagnostics for Multiple Sclerosis, by Region, 2022
Figure 21 : Global Market Shares of Autoimmune Disease Diagnostics for Inflammatory Bowel Disease, by Region, 2022
Figure 22 : Global Market Shares of Autoimmune Disease Diagnostics for Other Disease Indications, by Region, 2022
Figure 23 : Global Market Shares of Autoimmune Disease Diagnostics, by Technology, 2022
Figure 24 : Global Electricity Produced from Renewable Sources, 2017–2021
Figure 25 : Global Recycled Waste, 2017-2021
Figure 26 : Global CO2 Emissions, 2017–2021
Figure 27 : Global Company Market Shares of Autoimmune Disease Diagnostics, 2022
